Substantial rise in sparteine metabolic ratio during haloperidol treatment.
Authors:
Open Access
- 1 February 1989
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 27 (2) , 272-275
Abstract
A sparteine test was carried out in 14 patients suffering from acute schizophrenic psychoses before and 1‐2 times during oral haloperidol treatment in doses of 10‐40 mg day‐1. In patients classified as extensive metabolisers (sparteine MR less than 20 before treatment), haloperidol treatment resulted in a rise in sparteine MR that correlated with the serum‐haloperidol concentration both within and between patients. At the highest serum haloperidol concentrations (60‐ 80 nM) an increase in sparteine MR by a factor 15‐50 was seen, but no patients were transformed into phenotypically poor metabolisers. The steady state concentration of haloperidol on the initial standard dose of 10 mg day‐1 was the same in one patient classified as a sparteine poor metaboliser (MR = 112) as in eleven patients classified as extensive metabolisers (MR:0.22‐1.47).Keywords
This publication has 18 references indexed in Scilit:
- Quinidine and the identification of drugs whose elimination is impaired in subjects classified as poor metabolizers of debrisoquine.British Journal of Clinical Pharmacology, 1986
- Sparteine oxidation is practically abolished in quinidine-treated patients.British Journal of Clinical Pharmacology, 1986
- Pharmacokinetics and metabolism of quinidine in extensive and poor metabolisers of sparteineEuropean Journal of Clinical Pharmacology, 1986
- Steady-state levels of imipramine and its metabolites: Significance of dose-dependent kineticsEuropean Journal of Clinical Pharmacology, 1986
- Competitive inhibition of sparteine oxidation in human liver by β-adrenoceptor antagonists and other cardiovascular drugsLife Sciences, 1984
- Inhibition of sparteine oxidation in human liver by tricyclic antidepressants and other drugsLife Sciences, 1983
- Sparteine metabolism in Canadian CaucasiansClinical Pharmacology & Therapeutics, 1982
- Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in manLife Sciences, 1980
- A gas chromatographic method for determining haloperidolNaunyn-Schmiedeberg's Archives of Pharmacology, 1974
- Drug Interaction: Inhibitory Effect of Neuroleptics on Metabolism of Tricyclic Antidepressants in ManBMJ, 1972